Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Correction to: Lack of netrin-4 alters vascular remodeling in the retina.

Crespo-Garcia S, Reichhart N, Wigdahl J, Skosyrski S, Kociok N, Strauß O, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2019 Nov 15. doi: 10.1007/s00417-019-04539-0. [Epub ahead of print]

PMID:
31729555
2.

[Therapeutic Approaches for Dry Age-Related Macular Degeneration].

Joussen AM, Helbig H.

Klin Monbl Augenheilkd. 2019 Sep;236(9):1066-1067. doi: 10.1055/a-0969-6721. Epub 2019 Sep 11. German. No abstract available.

PMID:
31509856
3.

Lack of netrin-4 alters vascular remodeling in the retina.

Crespo-Garcia S, Reichhart N, Wigdahl J, Skosyrski S, Kociok N, Strauß O, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2179-2184. doi: 10.1007/s00417-019-04447-3. Epub 2019 Aug 26. Erratum in: Graefes Arch Clin Exp Ophthalmol. 2019 Nov 15;:.

PMID:
31451908
4.

[Pharmacotherapy of Non-neovascular AMD].

Zeitz O, Frentzel DP, Rübsam A, Seibel I, Riechardt AI, Brockmann C, Meißner F, Joussen AM.

Klin Monbl Augenheilkd. 2019 Sep;236(9):1076-1080. doi: 10.1055/a-0914-3183. Epub 2019 Jul 30. German.

PMID:
31362320
5.

Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment?

Eckstein D, Riechardt AI, Heufelder J, Zeitz O, Böker A, Brockmann C, Joussen AM, Seibel I.

Am J Ophthalmol. 2019 Dec;208:289-294. doi: 10.1016/j.ajo.2019.07.004. Epub 2019 Jul 16.

PMID:
31323201
6.

Breakdown of the blood-eye barrier in choroidal melanoma after proton beam radiotherapy.

Hager A, Meissner F, Riechardt AI, Bonaventura T, Löwen J, Heufelder J, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2323-2328. doi: 10.1007/s00417-019-04413-z. Epub 2019 Jul 12.

PMID:
31300898
7.

Systemic Rho-kinase inhibition using fasudil in mice with oxygen-induced retinopathy.

Brockmann C, Corkhill C, Jaroslawska E, Dege S, Brockmann T, Kociok N, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1699-1708. doi: 10.1007/s00417-019-04365-4. Epub 2019 May 31.

PMID:
31152312
8.

Living with Geographic Atrophy: An Ethnographic Study.

Sivaprasad S, Tschosik EA, Guymer RH, Kapre A, Suñer IJ, Joussen AM, Lanzetta P, Ferrara D.

Ophthalmol Ther. 2019 Mar;8(1):115-124. doi: 10.1007/s40123-019-0160-3. Epub 2019 Jan 31.

9.

Exploring the precision of femtosecond laser-assisted descemetorhexis in Descemet membrane endothelial keratoplasty.

Pilger D, von Sonnleithner C, Bertelmann E, Maier AB, Joussen AM, Torun N.

BMJ Open Ophthalmol. 2018 Dec 27;3(1):e000148. doi: 10.1136/bmjophth-2018-000148. eCollection 2018.

10.

The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial.

Joussen AM, Wolf S, Kaiser PK, Boyer D, Schmelter T, Sandbrink R, Zeitz O, Deeg G, Richter A, Zimmermann T, Hoechel J, Buetehorn U, Schmitt W, Stemper B, Boettger MK.

Br J Clin Pharmacol. 2019 Feb;85(2):347-355. doi: 10.1111/bcp.13794. Epub 2018 Nov 25.

PMID:
30341774
11.

Immunosuppressants and/or antivascular endothelial growth factor inhibitors in punctate inner choroidopathy? Follow-up results with optical coherence tomography angiography.

Pohlmann D, Pleyer U, Joussen AM, Winterhalter S.

Br J Ophthalmol. 2019 Aug;103(8):1152-1157. doi: 10.1136/bjophthalmol-2018-312455. Epub 2018 Oct 18.

PMID:
30337330
12.

[Multimodal Imaging of the Choroidal Melanoma, with Differential Diagnosis, Therapy (Radiation Planning) and Follow-up].

Nürnberg D, Seibel I, Riechardt AI, Brockmann C, Zeitz O, Heufelder J, Joussen AM.

Klin Monbl Augenheilkd. 2018 Sep;235(9):1001-1012. doi: 10.1055/a-0667-0806. Epub 2018 Sep 14. German.

PMID:
30216953
13.

[Ultra-Wide Field Retinal Imaging and Angiography in the Differential Diagnosis and Therapeutic Decisions in Vascular Diseases of the Peripheral Retina].

Joussen AM, Brockmann C, Urban J, Seibel I, Winterhalter S, Zeitz O, Müller B.

Klin Monbl Augenheilkd. 2018 Sep;235(9):980-993. doi: 10.1055/a-0667-0493. Epub 2018 Sep 14. German.

PMID:
30216952
14.

[Peripheral Ischemia in Diabetic Retinopathy and Retinal Vein Occlusion: New Insights with Ultra-Wide-Angle Fundus Imaging and Wide-Angle Fluorescein Angiography].

Böker A, Seibel I, Rübsam A, Joussen AM, Zeitz O.

Klin Monbl Augenheilkd. 2018 Sep;235(9):974-979. doi: 10.1055/a-0667-0706. Epub 2018 Sep 14. German.

PMID:
30216951
15.

[Widefield Diagnostics of the Posterior Segment].

Joussen AM, Helbig H.

Klin Monbl Augenheilkd. 2018 Sep;235(9):972-973. doi: 10.1055/a-0655-8840. Epub 2018 Sep 14. German. No abstract available.

PMID:
30216950
16.

Targeting myeloid cells in ischemic retinal vascular diseases.

Nürnberg C, Kociok N, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):1799-1800. doi: 10.1007/s00417-018-4107-5. Epub 2018 Aug 21. No abstract available.

PMID:
30132279
17.

[Peripheral Exudative Haemorrhagic Chorioretinopathy: Course of Disease and Diagnosis - Including Wide-field Imaging of Associated Diseases Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy, Therapy].

Seibel I, Nürnberg D, Löwen J, Winterhalter S, Zeitz O, Joussen AM.

Klin Monbl Augenheilkd. 2018 Sep;235(9):994-1000. doi: 10.1055/a-0656-6867. Epub 2018 Aug 10. German.

PMID:
30096725
18.

Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma.

Busch C, Löwen J, Pilger D, Seibel I, Heufelder J, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1599-1604. doi: 10.1007/s00417-018-4036-3. Epub 2018 Jun 12.

PMID:
29948179
19.

Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.

Böker A, Pilger D, Cordini D, Seibel I, Riechardt AI, Joussen AM, Bechrakis NE.

Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1767-1775. doi: 10.1007/s00417-018-4032-7. Epub 2018 Jun 16.

PMID:
29907945
20.

Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy.

Müller B, Tatsios J, Klonner J, Pilger D, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1581-1588. doi: 10.1007/s00417-018-4031-8. Epub 2018 Jun 6.

PMID:
29876733
21.

Correction: Individual and temporal variability of the retina after chronic bilateral common carotid artery occlusion (BCCAO).

Crespo-Garcia S, Reichhart N, Skosyrski S, Foddis M, Wu J, Figura A, Herrspiegel C, Füchtemeier M, Sassi C, Dirnagl U, Joussen AM, Strauss O.

PLoS One. 2018 Apr 23;13(4):e0196538. doi: 10.1371/journal.pone.0196538. eCollection 2018.

22.

Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.

Seibel I, Riechardt AI, Erb-Eigner K, Böker A, Cordini D, Heufelder J, Joussen AM.

Am J Ophthalmol. 2018 Jul;191:49-53. doi: 10.1016/j.ajo.2018.04.006. Epub 2018 Apr 12.

PMID:
29655645
23.

Optical coherence tomography angiography in comparison with other multimodal imaging techniques in punctate inner choroidopathy.

Pohlmann D, Pleyer U, Joussen AM, Winterhalter S.

Br J Ophthalmol. 2019 Jan;103(1):60-66. doi: 10.1136/bjophthalmol-2017-311764. Epub 2018 Mar 26.

PMID:
29581353
24.

Individual and temporal variability of the retina after chronic bilateral common carotid artery occlusion (BCCAO).

Crespo-Garcia S, Reichhart N, Skosyrski S, Foddis M, Wu J, Figura A, Herrspiegel C, Füchtemeier M, Sassi C, Dirnagl U, Joussen AM, Strauss O.

PLoS One. 2018 Mar 16;13(3):e0193961. doi: 10.1371/journal.pone.0193961. eCollection 2018. Erratum in: PLoS One. 2018 Apr 23;13(4):e0196538.

25.

Local partial depletion of CD11b+ cells and their influence on choroidal neovascularization using the CD11b-HSVTK mouse model.

Brockmann C, Kociok N, Dege S, Davids AM, Brockmann T, Miller KR, Joussen AM.

Acta Ophthalmol. 2018 Nov;96(7):e789-e796. doi: 10.1111/aos.13716. Epub 2018 Mar 14.

26.

Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.

Riechardt AI, Klein JP, Cordini D, Heufelder J, Rehak M, Seibel I, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1325-1332. doi: 10.1007/s00417-018-3929-5. Epub 2018 Feb 20.

PMID:
29464331
27.

ILM peeling in rhegmatogenous retinal detachment; does it improve the outcome?

Steel DH, Joussen AM, Wong D.

Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):247-248. doi: 10.1007/s00417-017-3876-6. Epub 2017 Dec 27. No abstract available.

PMID:
29282562
28.

Dataset on the activation of Müller cells through macrophages upon hypoxia in the retina.

Nürnberg C, Kociok N, Brockmann C, Lischke T, Crespo-Garcia S, Reichhart N, Wolf S, Baumgrass R, Eming SA, Beer-Hammer S, Joussen AM.

Data Brief. 2017 Nov 22;16:489-500. doi: 10.1016/j.dib.2017.11.062. eCollection 2018 Feb.

29.

Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series.

Winterhalter S, Behrens UD, Salchow D, Joussen AM, Pleyer U.

BMC Ophthalmol. 2017 Dec 16;17(1):252. doi: 10.1186/s12886-017-0648-3.

30.

Spatial distribution of CD115+ and CD11b+ cells and their temporal activation during oxygen-induced retinopathy in mice.

Brockmann C, Dege S, Crespo-Garcia S, Kociok N, Brockmann T, Strauß O, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):313-323. doi: 10.1007/s00417-017-3845-0. Epub 2017 Nov 28.

PMID:
29185100
31.

Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.

Winterhalter S, Eckert A, Vom Brocke GA, Schneider A, Pohlmann D, Pilger D, Joussen AM, Rehak M, Grittner U.

Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):267-279. doi: 10.1007/s00417-017-3852-1. Epub 2017 Nov 28.

PMID:
29185099
32.

Multimodal Imaging in Birdshot Retinochoroiditis.

Pohlmann D, Macedo S, Stübiger N, Pleyer U, Joussen AM, Winterhalter S.

Ocul Immunol Inflamm. 2017 Oct;25(5):621-632. doi: 10.1080/09273948.2017.1375532.

PMID:
29083980
33.

Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells.

Nürnberg C, Kociok N, Brockmann C, Lischke T, Crespo-Garcia S, Reichhart N, Wolf S, Baumgrass R, Eming SA, Beer-Hammer S, Joussen AM.

Exp Eye Res. 2018 Jan;166:56-69. doi: 10.1016/j.exer.2017.10.011. Epub 2017 Oct 14.

PMID:
29042140
34.

Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.

Crespo-Garcia S, Corkhill C, Roubeix C, Davids AM, Kociok N, Strauss O, Joussen AM, Reichhart N.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):4997-5006. doi: 10.1167/iovs.16-21283.

PMID:
28979997
35.

[Eye Drops Instead of Intravitreal Injections? The Dream of Treating Macular Diseases by Topically Administered Drugs].

Zeitz O, Joussen AM.

Klin Monbl Augenheilkd. 2017 Sep;234(9):1088-1093. doi: 10.1055/s-0043-113253. Epub 2017 Aug 11. Review. German.

PMID:
28800660
36.

Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.

Riechardt AI, Pilger D, Cordini D, Seibel I, Gundlach E, Hager A, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2263-2269. doi: 10.1007/s00417-017-3737-3. Epub 2017 Jul 18.

PMID:
28721444
37.

Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.

Riechardt AI, Karle B, Cordini D, Heufelder J, Budach V, Joussen AM, Gollrad J.

Strahlenther Onkol. 2017 Nov;193(11):943-950. doi: 10.1007/s00066-017-1166-1. Epub 2017 Jun 19.

PMID:
28631017
38.

Vascular-Associated Muc4/Vwf Co-Localization in Human Conjunctival Malignant Melanoma Specimens-Tumor Metastasis by Migration?

Kakkassery V, Winterhalter S, Nick AC, Joachim SC, Joussen AM, Kociok N.

Curr Eye Res. 2017 Oct;42(10):1382-1388. doi: 10.1080/02713683.2017.1324630. Epub 2017 Jun 16.

PMID:
28622066
39.

Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.

Seibel I, Riechardt AI, Heufelder J, Cordini D, Joussen AM.

Am J Ophthalmol. 2017 Jun;178:94-100. doi: 10.1016/j.ajo.2017.03.027. Epub 2017 Mar 30.

PMID:
28365241
40.

Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy.

Rübsam A, Thieme CE, Schlomberg J, Winterhalter S, Müller B, Joussen AM, Stübiger N.

J Ocul Pharmacol Ther. 2017 Apr;33(3):141-148. doi: 10.1089/jop.2016.0068. Epub 2017 Mar 9.

PMID:
28277988
41.

Netrin-4 Mediates Corneal Hemangiogenesis but Not Lymphangiogenesis in the Mouse-Model of Suture-Induced Neovascularization.

Maier AB, Klein S, Kociok N, Riechardt AI, Gundlach E, Reichhart N, Strauß O, Joussen AM.

Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1387-1396. doi: 10.1167/iovs.16-19249.

PMID:
28253401
42.

Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator.

Micklisch S, Lin Y, Jacob S, Karlstetter M, Dannhausen K, Dasari P, von der Heide M, Dahse HM, Schmölz L, Grassmann F, Alene M, Fauser S, Neumann H, Lorkowski S, Pauly D, Weber BH, Joussen AM, Langmann T, Zipfel PF, Skerka C.

J Neuroinflammation. 2017 Jan 5;14(1):4. doi: 10.1186/s12974-016-0776-3.

43.

Intraocular Pressure Measurements After Descemet Membrane Endothelial Keratoplasty.

Maier AK, Gundlach E, Pahlitzsch M, Gonnermann J, Corkhill C, Bertelmann E, Joussen AM, Klamann MK, Torun N.

J Glaucoma. 2017 Mar;26(3):258-265. doi: 10.1097/IJG.0000000000000593.

PMID:
27906816
44.

Retrospective, controlled observational case study of patients with central retinal vein occlusion and initially low visual acuity treated with an intravitreal dexamethasone implant.

Winterhalter S, Vom Brocke GA, Pilger D, Eckert A, Schlomberg J, Rübsam A, Klamann MK, Gundlach E, Dietrich-Ntoukas T, Joussen AM.

BMC Ophthalmol. 2016 Oct 27;16(1):187.

45.

The TetO rat as a new translational model for type 2 diabetic retinopathy by inducible insulin receptor knockdown.

Reichhart N, Crespo-Garcia S, Haase N, Golic M, Skosyrski S, Rübsam A, Herrspiegel C, Kociok N, Alenina N, Bader M, Dechend R, Strauss O, Joussen AM.

Diabetologia. 2017 Jan;60(1):202-211. Epub 2016 Oct 4.

PMID:
27704165
46.

[Ocular Hypotension: How the Retina Surgeon Sees the Causes and Therapeutic Options].

Joussen AM, Strauß O, Winterhalter S, Klamann M, Dietrich-Ntoukas T, Müller B.

Klin Monbl Augenheilkd. 2016 Sep;233(9):1024-32. doi: 10.1055/s-0042-109708. Epub 2016 Sep 12. Review. German.

PMID:
27617647
47.

[Editorial: Proliferative Vitreo-Retinopathy].

Helbig H, Joussen AM.

Klin Monbl Augenheilkd. 2016 Sep;233(9):1011. doi: 10.1055/s-0042-114587. Epub 2016 Sep 12. German. No abstract available.

PMID:
27617646
48.

Femtosecond Laser-Assisted Descemetorhexis: A Novel Technique in Descemet Membrane Endothelial Keratoplasty.

Pilger D, von Sonnleithner C, Bertelmann E, Joussen AM, Torun N.

Cornea. 2016 Oct;35(10):1274-8. doi: 10.1097/ICO.0000000000000987.

PMID:
27538189
49.

Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.

Seibel I, Cordini D, Hager A, Tillner J, Riechardt AI, Heufelder J, Davids AM, Rehak M, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2016 Sep;254(9):1787-92. doi: 10.1007/s00417-016-3429-4. Epub 2016 Jul 4.

PMID:
27376824
50.

PREDICTORS OF TREATMENT RESPONSE OF VASOPROLIFERATIVE RETINAL TUMORS TO RUTHENIUM-106 BRACHYTHERAPY.

Brockmann C, Rehak M, Heufelder J, Cordini D, Brockmann T, Corkhill C, Joussen AM, Hager A.

Retina. 2016 Dec;36(12):2384-2390.

PMID:
27322946

Supplemental Content

Loading ...
Support Center